20alpha-Hydroxycholesterol (BioCAD00000003199)
{$topic}
Metabolite Card
Formula: C27H46O2 (402.3498)
SMILES: CC(C)CCC[C@@](C)(O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Synonyms [en]
20-hydroxycholesterol; 20alpha-hydroxycholesterol; (20S)-20-hydroxycholesterol; 20(S)-hydroxycholesterol; cholest-5-ene-3beta,20-diol; 20(S)-OHC
Last reviewed on 2024-06-28.
Cite this Page
20alpha-Hydroxycholesterol. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000003199). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
20 alpha-hydroxycholesterol participates in C21-Steroid hormone metabolism. 20 alpha-hydroxycholesterol is produced by the reaction between cholesterol and the enzyme, cholesterol monooxygenase (side-chain-cleaving) [EC:1.14.15.6].
DBLinks
- CAS Registry Number: 516-72-3
- PubChem CID: 440711
- ChEBI: 1296
- HMDB: HMDB0006283
- LipidMaps: LMST01010201
- KEGG: C05500
- BioCyc: 2-HYDROXY-CHOLESTEROL
- NCBI MeSH: 20-hydroxycholesterol
- Wikipedia: 20S-Hydroxycholesterol
Other DBLinks
- CAS Registry Number: 516-72-3
- PubChem: 121935
- PubChem: 24779600
- PubChem: 440711
- ChEBI: ChEBI:1296
- ChEBI: ChEBI:166801
- HMDB: HMDB0006283
- LipidMaps: LMST01010201
- LipidMaps: LMST01010211
- KEGG: C05500
- BioCyc: 2-HYDROXY-CHOLESTEROL
- NCBI MeSH: 20-hydroxycholesterol
- Wikipedia: 20S-Hydroxycholesterol
- DrugBank: DB04704
- RefMet: RM0018306
- RefMet: RM0135688
- Metlin: METLIN_24053
- Coconut NaturalProduct: CNP0347064.1
- Coconut NaturalProduct: CNP0347064.2
Class / Ontology
- WishartLab ClassyFire: [Cholestane steroids] Cholestane steroids
- RefMet: [Cholesterols] Cholesterols
- RefMet: [Oxysterols] Oxysterols
- LipidMaps: [Cholesterol and derivatives [ST0101]] Cholesterol and derivatives [ST0101]
- ChEBI: [CHEBI:1296] 20-hydroxycholesterol
- Coconut NaturalProduct: [Cholestane steroids] Cholestane steroids
| ID | EC Number | Name |
|---|---|---|
| KEGG:R01454 | 1.14.15.6 | cholesterol:oxygen oxidoreductase (side-chain-cleaving) |
| KEGG:R04853 | 1.14.14.19 | 20alpha-hydroxycholesterol,NADPH-hemoprotein reductase:oxygen oxidoreductase (17alpha-hydroxylating) |
| KEGG:R04854 | 1.14.15.6 | 20alpha-hydroxycholesterol:oxygen oxidoreductase (side-chain-cleaving) |
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| PathBank:SMP0120690 | Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
| PathBank:SMP0120858 | 11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0120641 | Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0120649 | Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0000373 | Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency |
| PathBank:SMP0000576 | 21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0000718 | 3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0087238 | Steroidogenesis |
| PathBank:SMP0120849 | 17-alpha-Hydroxylase Deficiency (CYP17) |
| PathBank:SMP0120861 | Corticosterone Methyl Oxidase II Deficiency (CMO II) |
| PathBank:SMP0120869 | 3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0120451 | Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0120640 | 21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0000575 | 11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0000717 | Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0063672 | Steroidogenesis |
| PathBank:SMP0120672 | Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0120860 | Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0120868 | Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0120630 | 17-alpha-Hydroxylase Deficiency (CYP17) |